Consultation outcome

Distributing vaccines and treatments for COVID-19 and flu

From:
Department of Health and Social Care
Published
28 August 2020
Last updated
5 August 2021 — See all updates
This was published under the 2019 to 2022 Johnson Conservative government
This consultation has concluded

Read the full outcome

Government response: consultation on changes to the Human Medicines Regulations to support the rollout of COVID-19 and flu vaccines

HTML

Detail of outcome

The government hosted a public consultation from 28 August to 18 September on changes to the Human Medicines Regulations to support the rollout of COVID-19 vaccines. This is the formal government response to that consultation.

Original consultation

Summary

We want your views on proposed changes to the Human Medicine Regulations to help with the safe and efficient distribution of a COVID-19 vaccine and expanded flu vaccine programme in the UK, along with treatments for COVID-19 and any other diseases that become pandemic.

This consultation ran from
to

Consultation description

The UK government, with the Minister of Health in Northern Ireland, is seeking views on proposed changes to the Human Medicine Regulations 2012.

The consultation covers:

  • authorising temporary supply of an unlicensed product
  • civil liability and immunity
  • expanding the workforce eligible to administer vaccinations
  • promoting vaccines
  • making provisions for wholesale dealing of vaccines

Documents

Consultation document: changes to Human Medicine Regulations to support the rollout of COVID-19 vaccines

HTML

Draft statutory instrument: the Human Medicines (Coronavirus) (Amendment) Regulations 2020

PDF, 147 KB, 12 pages

Updates to this page

Published 28 August 2020
Last updated 5 August 2021 + show all updates

  1. In the consultation response, amended point 1 under 'Summary of changes' and the call-out box for 'Change 1' (under 'Attaching conditions to a temporarily authorised vaccine') to refer to regulation 174A (not 174). The impact of regulation 174A will be formally reviewed as soon as practicable after a year of any first use.

  2. Added the final outcome document.

  3. First published.

Sign up for emails or print this page